Biomarkers in solid organ transplantation: Establishing personalized transplantation medicine

Genome Medicine

Volumn 3, Issue 6, 2011, Pages

  Roedder, Silke ^a   Vitalone, Matthew ^a   Khatri, Purvesh ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; ANTIBODY; BIOLOGICAL MARKER; CD31 ANTIGEN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR; COMPLEMENT COMPONENT C3; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CXCL9 CHEMOKINE; CYTOTOXIC FACTOR; DNA; DUFFY BINDING PROTEIN; FAS LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLOBIN MESSENGER RNA; GRANZYME; HLA ANTIGEN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOSUPPRESSIVE AGENT; KIDNEY INJURY MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNOSIDASE; MICRORNA; PEPTIDE; PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTOME;

ACUTE GRAFT REJECTION; ALGORITHM; ALLOGRAFT; APOPTOSIS; B LYMPHOCYTE; BIOPSY; BLOOD; BLOOD GROUP KIDD SYSTEM; CADAVER DONOR; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CELL TYPE; COLD ISCHEMIA; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE SEVERITY; DNA HYBRIDIZATION; DONOR; FIBROSING ALVEOLITIS; FINGER DERMATOGLYPHICS; FOOD AND DRUG ADMINISTRATION; FORCE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPOXIA; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; KILLER CELL; LIFESTYLE; LIVER TRANSPLANTATION; LIVING DONOR; LUNG TRANSPLANTATION; LYMPHOCYTE; MEMORY T LYMPHOCYTE; METABOLITE; MICROARRAY ANALYSIS; MONOCYTE; NEUTROPHIL; ORGAN INJURY; ORGAN TRANSPLANTATION; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SAFETY; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERATURE; UNITED STATES; UNSPECIFIED SIDE EFFECT; UPREGULATION; URINE; VALIDATION PROCESS; VASCULARIZATION;

EID: 79960630579     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm253     Document Type: Review

References (100)

1. Khatri P, Sarwal MM. Using gene arrays in diagnosis of rejection. Curr Opin Organ Transplant 2009, 14:34-39. 10.1097/MOT.0b013e32831e13d0, 19337144.
2. Sigdel TK, Klassen RB, Sarwal MM. Interpreting the proteome and peptidome in transplantation. Adv Clin Chem 2009, 47:139-169.
3. Sigdel TK, Sarwal MM. The proteogenomic path towards biomarker discovery. Pediatr Transplant 2008, 12:737-747. 10.1111/j.1399-3046.2008.01018.x, 2574627, 18764911.
4. Ying L, Sarwal M. In praise of arrays. Pediatr Nephrol 2009, 24:1643-1659. quiz 1655, 1659, 10.1007/s00467-008-0808-z, 2719727, 18568367.
5. AlloMap; A non-invasive gene expression test (XDx Diagnostics). , http://www.allomap.com/
6. Naesens M, Sarwal MM. Molecular diagnostics in transplantation. Nat Rev Nephrol 2010, 6:614-628. 10.1038/nrneph.2010.113, 20736923.
7. Rodder S, Scherer A, Korner M, Eisenberger U, Hertig A, Raulf F, Rondeau E, Marti HP. Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients. Am J Transplant 2010, 10:286-297. 10.1111/j.1600-6143.2009.02928.x, 19958327.
8. Rodder S, Scherer A, Raulf F, Berthier CC, Hertig A, Couzi L, Durrbach A, Rondeau E, Marti HP. Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009, 9:517-526. 10.1111/j.1600-6143.2008.02512.x, 19191772.
9. Kong X, Mas V, Archer KJ. A non-parametric meta-analysis approach for combining independent microarray datasets: application using two microarray datasets pertaining to chronic allograft nephropathy. BMC Genomics 2008, 9:98. 10.1186/1471-2164-9-98, 2276496, 18302764.
10. Park WD, Stegall MD. A meta-analysis of kidney microarray datasets: investigation of cytokine gene detection and correlation with RT-PCR and detection thresholds. BMC Genomics 2007, 8:88. 10.1186/1471-2164-8-88, 1852103, 17397532.
11. Ling XB, Sigdel TK, Lau K, Ying L, Lau I, Schilling J, Sarwal MM. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol 2010, 21:646-653. 10.1681/ASN.2009080876, 2844301, 20150539.
12. Li L, Wadia P, Chen R, Kambham N, Naesens M, Sigdel TK, Miklos DB, Sarwal MM, Butte AJ. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 2009, 106:4148-4153. 10.1073/pnas.0900563106, 2657434, 19251643.
13. Kurian SM, Heilman R, Mondala TS, Nakorchevsky A, Hewel JA, Campbell D, Robison EH, Wang L, Lin W, Gaber L, Solez K, Shidban H, Mendez R, Schaffer RL, Fisher JS, Flechner SM, Head SR, Horvath S, Yates JR, Marsh CL, Salomon DR. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One 2009, 4:e6212. 10.1371/journal.pone.0006212, 2703807, 19593431.
14. Brouard S, Mansfield E, Braud C, Li L, Giral M, Hsieh SC, Baeten D, Zhang M, Ashton-Chess J, Braudeau C, Hsieh F, Dupont A, Pallier A, Moreau A, Louis S, Ruiz C, Salvatierra O, Soulillou JP, Sarwal M. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007, 104:15448-15453. 10.1073/pnas.0705834104, 2000539, 17873064.
15. Li SH, Scandling J, Sigdel T, Sarwal M. A highly specific novel 3 gene-set can non-invasively predict operational renal allograft tolerance (#334). Am J Transplant 2010, 10:1.
16. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006, 24:1151-1161. 10.1038/nbt1239, 16964229.
17. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD, Oberthuer A, Thomas RS, Paules RS, Fielden M, Barlogie B, Chen W, Du P, Fischer M, Furlanello C, Gallas BD, Ge X, Megherbi DB, Symmans WF, Wang MD, Zhang J, Bitter H, Brors B, Bushel PR, Bylesjo M, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010, 28:827-838. 10.1038/nbt.1665, 20676074.
18. Gautam A, Morrissey PE, Brem AS, Fischer SA, Gohh RY, Yango AF, Monaco AP. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 2006, 10:613-616. 10.1111/j.1399-3046.2006.00510.x, 16856999.
19. Kowalski RJ, Post DR, Mannon RB, Sebastian A, Wright HI, Sigle G, Burdick J, Elmagd KA, Zeevi A, Lopez-Cepero M, Daller JA, Gritsch HA, Reed EF, Jonsson J, Hawkins D, Britz JA. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006, 82:663-668.
20. Debey S, Schoenbeck U, Hellmich M, Gathof BS, Pillai R, Zander T, Schultze JL. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 2004, 4:193-207. 10.1038/sj.tpj.6500240, 15037859.
21. Veale JL, Liang LW, Zhang Q, Gjertson DW, Du Z, Bloomquist EW, Jia J, Qian L, Wilkinson AH, Danovitch GM, Pham PT, Rosenthal JT, Lassman CR, Braun J, Reed EF, Gritsch HA. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol 2006, 67:777-786. 10.1016/j.humimm.2006.07.006, 17055354.
22. Alakulppi NS, Kyllonen LE, Partanen J, Salmela KT, Laine JT. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation 2007, 83:791-798. 10.1097/01.tp.0000258726.13363.ab, 17414714.
23. Graziotto R, Del Prete D, Rigotti P, Anglani F, Baldan N, Furian L, Valente M, Antonello A, Marchini F, D'Angelo A, Gambaro G. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. Transplantation 2006, 81:1125-1132. 10.1097/01.tp.0000208573.16839.67, 16641597.
24. Shin GT, Kim SJ, Lee TS, Oh CK, Kim H. Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection. Nephron Clin Pract 2005, 100:c63-c70. 10.1159/000085050, 15824509.
25. Simon T, Opelz G, Weimer R, Wiesel M, Feustel A, Ott RC, Susal C. The effect of ATG on cytokine and cytotoxic T-lymphocyte gene expression in renal allograft recipients during the early post-transplant period. Clin Transplant 2003, 17:217-224. 10.1034/j.1399-0012.2003.00031.x, 12780671.
26. Netto MV, Fonseca BA, Dantas M, Saber LT, Castro MC, Ferraz AS. Granzyme B, FAS-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation: comparison between blood and renal aspirates. Transplant Proc 2002, 34:476-478. 10.1016/S0041-1345(02)02601-5, 12009596.
27. Vasconcellos LM, Schachter AD, Zheng XX, Vasconcellos LH, Shapiro M, Harmon WE, Strom TB. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998, 66:562-566. 10.1097/00007890-199809150-00002, 9753332.
28. Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, Bumgarner RE, Bushel PR, Chaturvedi K, Choi D, Cunningham ML, Deng S, Dressman HK, Fannin RD, Farin FM, Freedman JH, Fry RC, Harper A, Humble MC, Hurban P, Kavanagh TJ, Kaufmann WK, Kerr KF, Jing L, Lapidus JA, Lasarev MR, Li J, Li YJ, Lobenhofer EK, Lu X, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005, 2:351-356. 10.1038/nmeth754, 15846362.
29. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, Herdman C, Bankaitis-Davis D, Nicholls N, Trollinger D, Tryon V. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002, 48:1883-1890.
30. Debey S, Zander T, Brors B, Popov A, Eils R, Schultze JL. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics 2006, 87:653-664. 10.1016/j.ygeno.2005.11.010, 16387473.
31. Li L, Ying L, Naesens M, Xiao W, Sigdel T, Hsieh S, Martin J, Chen R, Liu K, Mindrinos M, Davis R, Sarwal M. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol Genomics 2008, 32:190-197.
32. Min JL, Barrett A, Watts T, Pettersson FH, Lockstone HE, Lindgren CM, Taylor JM, Allen M, Zondervan KT, McCarthy MI. Variability of gene expression profiles in human blood and lymphoblastoid cell lines. BMC Genomics 2010, 11:96. 10.1186/1471-2164-11-96, 2841682, 20141636.
33. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003, 100:1896-1901. 10.1073/pnas.252784499, 149930, 12578971.
34. Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, Fay A, MacMillan S, Laramie J, Xiao W, Moldawer LL, Cobb JP, Laudanski K, Miller-Graziano CL, Maier RV, Schoenfeld D, Davis RW, Tompkins RG. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004, 19:247-254. 10.1152/physiolgenomics.00020.2004, 15548831.
35. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, Perry NM, Hastie T, Sarwal MM, Davis MM, Butte AJ. Cell type-specific gene expression differences in complex tissues. Nat Methods 2010, 7:287-289. 10.1038/nmeth.1439, 20208531.
36. Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One 2009, 4:e6098. 10.1371/journal.pone.0006098, 2699551, 19568420.
37. Repsilber D, Kern S, Telaar A, Walzl G, Black GF, Selbig J, Parida SK, Kaufmann SH, Jacobsen M. Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach. BMC Bioinformatics 2010, 11:27. 10.1186/1471-2105-11-27, 3098067, 20070912.
38. Terasaki P, Lachmann N, Cai J. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure. Clin Transpl 2006, 455-462.
39. Israni A, Leduc R, Holmes J, Jacobson PA, Lamba V, Guan W, Schladt D, Chen J, Matas AJ, Oetting WS. Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation. Transplantation 2010, 90:1401-1408. 10.1097/TP.0b013e3182000085, 21085059.
40. Kruger B, Banas MC, Walberer A, Boger CA, Farkas S, Hoffmann U, Fischereder M, Banas B, Kramer BK. A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond) 2010, 119:535-544.
41. Dhillon N, Walsh L, Kruger B, Ward SC, Godbold JH, Radwan M, Schiano T, Murphy BT, Schroppel B. A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J Hepatol 2010, 53:67-72. 10.1016/j.jhep.2009.12.044, 20400193.
42. Ducloux D, Deschamps M, Yannaraki M, Ferrand C, Bamoulid J, Saas P, Kazory A, Chalopin JM, Tiberghien P. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005, 67:2454-2461. 10.1111/j.1523-1755.2005.00354.x, 15882292.
43. Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 2007, 84:511-516. 10.1097/01.tp.0000276960.35313.bf, 17713436.
44. Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang JI, Park MH, Kim S, Yang J, Ahn C. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 2009, 88:699-705. 10.1097/TP.0b013e3181b2f34a, 19741468.
45. Kastelijn EA, van Moorsel CH, Rijkers GT, Ruven HJ, Karthaus V, Kwakkel-van Erp JM, van de Graaf EA, Zanen P, van Kessel DA, Grutters JC, van den Bosch JM. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 2010, 29:665-671. 10.1016/j.healun.2009.12.013, 20227302.
46. Naesens M, Butte AJ, Sarwal MM. C3 polymorphisms and outcomes of renal allografts. N Engl J Med 2009, 360:2478-2479. 19504761, 19504761 .
47. Naesens M, Li L, Ying L, Sansanwal P, Sigdel TK, Hsieh SC, Kambham N, Lerut E, Salvatierra O, Butte AJ, Sarwal MM. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 2009, 20:1839-1851. 10.1681/ASN.2008111145, 2723986, 19443638.
48. Sutherland SM, Li L, Sigdel TK, Wadia PP, Miklos DB, Butte AJ, Sarwal MM. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int 2009, 76:1277-1283. 10.1038/ki.2009.384, 19812540.
49. Li L, Chen A, Chaudhuri A, Kambham N, Sigdel T, Chen R, Sarwal MM. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010, 89:312-319. 10.1097/TP.0b013e3181bbbe4c, 2820825, 20145522.
50. Zou Y, Stastny P, Susal C, Dohler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007, 357:1293-1300. 10.1056/NEJMoa067160, 17898098.
51. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349:125-138. 10.1056/NEJMoa035588, 12853585.
52. Hertz MI, Aurora P, Christie JD, Dobbels F, Edwards LB, Kirk R, Kucheryavaya AY, Rahmel AO, Rowe AW, Stehlik J, Taylor DO. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports. J Heart Lung Transplant 2009, 28:989-992. 10.1016/j.healun.2009.08.005, 19782281.
53. National Institutes of Health U.S. Renal Data System, USRDS 2010 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health., http://www.usrds.org/adr.htm
54. Choy JC. Granzymes and perforin in solid organ transplant rejection. Cell Death Differ 2010, 17:567-576. 10.1038/cdd.2009.161, 19876069.
55. Sarwal MM, Jani A, Chang S, Huie P, Wang Z, Salvatierra O, Clayberger C, Sibley R, Krensky AM, Pavlakis M. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 2001, 62:21-31. 10.1016/S0198-8859(00)00228-7, 11165712.
56. Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, Serur D, Mouradian J, Schwartz JE, Suthanthiran M. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001, 344:947-954. 10.1056/NEJM200103293441301, 11274620.
57. Kotsch K, Mashreghi MF, Bold G, Tretow P, Beyer J, Matz M, Hoerstrup J, Pratschke J, Ding R, Suthanthiran M, Volk HD, Reinke P. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004, 77:1866-1875. 10.1097/01.TP.0000131157.19937.3F, 15223905.
58. Galante NZ, Camara NO, Kallas EG, Salomao R, Pacheco-Silva A, Medina-Pestana JO. Noninvasive immune monitoring assessed by flow cytometry and real time RT-PCR in urine of renal transplantation recipients. Transpl Immunol 2006, 16:73-80. 10.1016/j.trim.2006.03.014, 16860708.
59. Krukemeyer MG, Moeller J, Morawietz L, Rudolph B, Neumann U, Theruvath T, Neuhaus P, Krenn V. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection. Transplantation 2004, 78:65-70.
60. Hauser IA, Spiegler S, Kiss E, Gauer S, Sichler O, Scheuermann EH, Ackermann H, Pfeilschifter JM, Geiger H, Grone HJ, Radeke HH. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol 2005, 16:1849-1858. 10.1681/ASN.2004100836, 15857922.
61. Schaub S, Nickerson P, Rush D, Mayr M, Hess C, Golian M, Stefura W, Hayglass K. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant 2009, 9:1347-1353. 10.1111/j.1600-6143.2009.02645.x, 19459809.
62. Belperio JA, Keane MP, Burdick MD, Lynch JP, Zisman DA, Xue YY, Li K, Ardehali A, Ross DJ, Strieter RM. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 2003, 171:4844-4852.
63. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001, 193:975-980. 10.1084/jem.193.8.975, 2193411, 11304558.
64. Shyu AB, Wilkinson MF, van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J 2008, 27:471-481. 10.1038/sj.emboj.7601977, 2241649, 18256698.
65. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009, 106:5330-5335. 10.1073/pnas.0813121106, 2663998, 19289845.
66. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010, 33:607-619. 10.1016/j.immuni.2010.09.009, 20888269.
67. Harris A, Krams SM, Martinez OM. MicroRNAs as immune regulators: implications for transplantation. Am J Transplant 2010, 10:713-719. 10.1111/j.1600-6143.2010.03032.x, 2887485, 20199506.
68. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008, 3(Suppl 2):S68-S75.
69. Teschner S, Gerke P, Geyer M, Wilpert J, Krumme B, Benzing T, Walz G. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection. Transplant Proc 2009, 41:2533-2538. 10.1016/j.transproceed.2009.06.099, 19715969.
70. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009, 9:2312-2323. 10.1111/j.1600-6143.2009.02761.x, 19681822.
71. Zarkhin V, Kambham N, Li L, Kwok S, Hsieh SC, Salvatierra O, Sarwal MM. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008, 74:664-673. 10.1038/ki.2008.249, 18547992.
72. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005, 352:558-569. 10.1056/NEJMoa035717, 15703421.
73. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007, 7:408-415. 10.1111/j.1600-6143.2006.01644.x, 17229080.
74. Lerut E, Van Damme B, Noizat-Pirenne F, Emonds MP, Rouger P, Vanrenterghem Y, Pirenne J, Ansart-Pirenne H. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?. Transfusion 2007, 47:28-40. 10.1111/j.1537-2995.2007.01060.x, 17207227.
75. Joosten SA, Sijpkens YW, van Ham V, Trouw LA, van der Vlag J, van den Heuvel B, van Kooten C, Paul LC. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005, 5:383-393. 10.1111/j.1600-6143.2005.00690.x, 15643999.
76. Chen R, Sigdel TK, Li L, Kambham N, Dudley JT, Hsieh SC, Klassen RB, Chen A, Caohuu T, Morgan AA, Valantine HA, Khush KK, Sarwal MM, Butte AJ. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol 2010, 6:e1000940. 10.1371/journal.pcbi.1000940, 2944782, 20885780.
77. Ashton-Chess J, Giral M, Mengel M, Renaudin K, Foucher Y, Gwinner W, Braud C, Dugast E, Quillard T, Thebault P, Chiffoleau E, Braudeau C, Charreau B, Soulillou JP, Brouard S. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008, 19:1116-1127. 10.1681/ASN.2007101056, 2396937, 18369086.
78. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 2002, 14:681-685. 10.1097/00002281-200211000-00009, 12410091.
79. Booth AJ, Csencsits-Smith K, Wood SC, Lu G, Lipson KE, Bishop DK. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant 2010, 10:220-230. 10.1111/j.1600-6143.2009.02826.x, 2860022, 19788504.
80. Shi Y, Tu Z, Bao J, Sun H, Wang W, Luo G, Li S, Li Y, Bu H. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury. Scand J Urol Nephrol 2009, 43:390-399. 10.3109/00365520903142244, 19921985.
81. Luo GH, Lu YP, Song J, Yang L, Shi YJ, Li YP. Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy. Transplant Proc 2008, 40:2365-2369. 10.1016/j.transproceed.2008.07.100, 18790236.
82. Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts. Transplantation 2010, 90:394-400.
83. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007, 212:209-217. 10.1002/path.2175, 17471468.
84. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002, 62:237-244. 10.1046/j.1523-1755.2002.00433.x, 12081583.
85. Malyszko J, Koc-Zorawska E, Malyszko JS, Mysliwiec M. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients. Transplant Proc 2010, 42:3957-3959. 10.1016/j.transproceed.2010.10.005, 21168598.
86. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007, 84:1625-1630. 10.1097/01.tp.0000295982.78039.ef, 2745062, 18165774.
87. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 2008, 101:159-170. 2744478, 17934191.
88. Orlando G, Hematti P, Stratta RJ, Burke GW, Cocco PD, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg 2010, 252:915-928. 10.1097/SLA.0b013e3181f3efb0, 21107102.
89. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008, 118:2845-2857. 2483684, 18654667.
90. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Turka LA, Seyfert-Margolis VL, . Immune Tolerance Network ST507 Study Group Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836-1847. 10.1172/JCI39933, 2877933, 20501946, Immune Tolerance Network ST507 Study Group.
91. Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, Rovis F, Jimenez E, Ballow A, Giral M, Rebollo-Mesa I, Le Moine A, Braudeau C, Hilton R, Gerstmayer B, Bourcier K, Sharif A, Krajewska M, Lord GM, Roberts I, Goldman M, Wood KJ, Newell K, Seyfert-Margolis V, Warrens AN, Janssen U, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010, 120:1848-1861. 10.1172/JCI39922, 2877932, 20501943.
92. Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Walther D, Lal PG, Rosenberg S, Hunt S. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006, 6:150-160. 10.1111/j.1600-6143.2005.01175.x, 16433769.
93. Bernstein D, Williams GE, Eisen H, Mital S, Wohlgemuth JG, Klingler TM, Fang KC, Deng MC, Kobashigawa J. Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients. J Heart Lung Transplant 2007, 26:1270-1280. 10.1016/j.healun.2007.09.017, 18096478.
94. Perez-Flores I, Sanchez-Fructuoso A, Santiago JL, Fernandez-Arquero M, Calvo N, de la Concha EG, Barrientos A. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. Transplant Proc 2009, 41:2106-2108. 10.1016/j.transproceed.2009.06.136, 19715845.
95. Reinsmoen NL, Cornett KM, Kloehn R, Burnette AD, McHugh L, Flewellen BK, Matas A, Savik K. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation 2008, 85:462-470. 10.1097/TP.0b013e3181612ead, 18301338.
96. Sanchez-Velasco P, Rodrigo E, Valero R, Ruiz JC, Fernandez-Fresnedo G, Lopez-Hoyos M, Pinera C, Palomar R, Leyva-Cobian F, Arias M. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection. Clin Transplant 2008, 22:55-60.
97. Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, Machicao V, Levy C, Nelson D, Morelli G. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl 2009, 15:216-222. 10.1002/lt.21666, 19177434.
98. Rossano JW, Denfield SW, Kim JJ, Price JF, Jefferies JL, Decker JA, Smith EO, Clunie SK, Towbin JA, Dreyer WJ. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant 2009, 28:26-31. 10.1016/j.healun.2008.10.001, 19134527.
99. Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008, 27:990-994. 10.1016/j.healun.2008.06.005, 18765191.
100. Cadillo-Chavez R, de Echegaray S, Santiago-Delpin EA, Rodriguez-Trinidad AT, Camacho-Carrazo B, Alfaro T, Saavedra-Pozo M, Carrasquillo L, Gonzalez-Caraballo ZA, Morales-Otero LA. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 2006, 38:918-920. 10.1016/j.transproceed.2006.02.051, 16647510.